Publications in collaboration with researchers from Centro de Investigaciones Biológicas (3)

2013

  1. In vitro and in vivo effects of an anti-mouse endoglin (CD105)-immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours

    Cancer Immunology, Immunotherapy, Vol. 62, Núm. 3, pp. 541-551

2012

  1. Transient injury-dependent up-regulation of CD105 and its specific targeting with an anti-vascular anti-mouse endoglin-nigrin b immunotoxin

    Medicinal Chemistry, Vol. 8, Núm. 6, pp. 996-1002

2007

  1. Targeting a marker of the tumour neovasculature using a novel anti-human CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b

    Cancer Letters, Vol. 256, Núm. 1, pp. 73-80